Dr. Larry Schook and members of his lab team traveled to Copenhagen, Denmark to continue discussions with professors from the National Veterinary Institute at the Technical University of Denmark about a collaborative research project. The Schook lab will work with Dr. Gregers Jungerson and other researchers at the Institute to validate an anti-cancer vaccine using the OncopigTM.
This is the first anti-cancer vaccine studied an a large animal model. Previous development of therapeutic cancer vaccines has largely been based on studies in mice, and the majority of these candidate vaccines failed to induce therapeutic responses in the subsequent human clinical trials. Given that the antigen dose and vaccine volume in pigs are translatable to humans and the porcine immunome is closer related to the human counterpart, the OncopigTM will be used to validate novel anti-cancer vaccines.